nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP3A4—bone cancer	0.568	1	CbGaD
Sertraline—CYP2B6—Cisplatin—bone cancer	0.0406	0.255	CbGbCtD
Sertraline—CYP2B6—Doxorubicin—bone cancer	0.0272	0.171	CbGbCtD
Sertraline—CYP2C9—Cisplatin—bone cancer	0.0215	0.135	CbGbCtD
Sertraline—ABCB1—Cisplatin—bone cancer	0.0208	0.131	CbGbCtD
Sertraline—ABCB1—Doxorubicin—bone cancer	0.014	0.0877	CbGbCtD
Sertraline—ABCB1—Methotrexate—bone cancer	0.0135	0.085	CbGbCtD
Sertraline—CYP2D6—Doxorubicin—bone cancer	0.0131	0.0827	CbGbCtD
Sertraline—CYP3A4—Doxorubicin—bone cancer	0.00836	0.0526	CbGbCtD
Sertraline—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00194	0.0506	CbGpPWpGaD
Sertraline—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00108	0.0283	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—FEV—bone cancer	0.000997	0.026	CbGpPWpGaD
Sertraline—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.000911	0.0237	CbGpPWpGaD
Sertraline—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00082	0.0213	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—FEV—bone cancer	0.000817	0.0213	CbGpPWpGaD
Sertraline—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000803	0.0209	CbGpPWpGaD
Sertraline—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000757	0.0197	CbGpPWpGaD
Sertraline—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000754	0.0196	CbGpPWpGaD
Sertraline—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000753	0.0196	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000751	0.0196	CbGpPWpGaD
Sertraline—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000747	0.0195	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000714	0.0186	CbGpPWpGaD
Sertraline—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000714	0.0186	CbGpPWpGaD
Sertraline—MAOB—Tryptophan metabolism—CYP3A4—bone cancer	0.000684	0.0178	CbGpPWpGaD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000639	0.0166	CbGpPWpGaD
Sertraline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000586	0.0153	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000524	0.0137	CbGpPWpGaD
Sertraline—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000523	0.0136	CbGpPWpGaD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000493	0.0128	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000467	0.0122	CbGpPWpGaD
Sertraline—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000464	0.0121	CbGpPWpGaD
Sertraline—MAOB—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000448	0.0117	CbGpPWpGaD
Sertraline—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00044	0.0115	CbGpPWpGaD
Sertraline—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000435	0.0113	CbGpPWpGaD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000432	0.0113	CbGpPWpGaD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000404	0.0105	CbGpPWpGaD
Sertraline—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000396	0.0103	CbGpPWpGaD
Sertraline—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.00038	0.00991	CbGpPWpGaD
Sertraline—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000368	0.0096	CbGpPWpGaD
Sertraline—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000364	0.00948	CbGpPWpGaD
Sertraline—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000361	0.00939	CbGpPWpGaD
Sertraline—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000359	0.00936	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000353	0.00919	CbGpPWpGaD
Sertraline—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00035	0.00911	CbGpPWpGaD
Sertraline—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000347	0.00903	CbGpPWpGaD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000345	0.00899	CbGpPWpGaD
Sertraline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000342	0.00892	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000335	0.00873	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000324	0.00845	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000322	0.00838	CbGpPWpGaD
Sertraline—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000321	0.00836	CbGpPWpGaD
Sertraline—MAOB—Tryptophan metabolism—MDM2—bone cancer	0.000314	0.00819	CbGpPWpGaD
Sertraline—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000308	0.00803	CbGpPWpGaD
Sertraline—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000296	0.00772	CbGpPWpGaD
Sertraline—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000281	0.00733	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000275	0.00716	CbGpPWpGaD
Sertraline—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000272	0.00707	CbGpPWpGaD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000266	0.00694	CbGpPWpGaD
Sertraline—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000265	0.0069	CbGpPWpGaD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000253	0.00658	CbGpPWpGaD
Sertraline—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000248	0.00645	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—CYP3A4—bone cancer	0.000238	0.0062	CbGpPWpGaD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000236	0.00614	CbGpPWpGaD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000217	0.00566	CbGpPWpGaD
Sertraline—Erythema multiforme—Methotrexate—bone cancer	0.000215	0.000918	CcSEcCtD
Sertraline—Neuropathy peripheral—Doxorubicin—bone cancer	0.000215	0.000918	CcSEcCtD
Sertraline—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000214	0.00559	CbGpPWpGaD
Sertraline—Haemoglobin—Epirubicin—bone cancer	0.000214	0.000913	CcSEcCtD
Sertraline—Stomatitis—Doxorubicin—bone cancer	0.000214	0.000913	CcSEcCtD
Sertraline—Jaundice—Doxorubicin—bone cancer	0.000214	0.000913	CcSEcCtD
Sertraline—Rhinitis—Epirubicin—bone cancer	0.000213	0.000911	CcSEcCtD
Sertraline—Conjunctivitis—Doxorubicin—bone cancer	0.000213	0.00091	CcSEcCtD
Sertraline—Hepatitis—Epirubicin—bone cancer	0.000213	0.000909	CcSEcCtD
Sertraline—Haemorrhage—Epirubicin—bone cancer	0.000213	0.000909	CcSEcCtD
Sertraline—Eye disorder—Methotrexate—bone cancer	0.000213	0.000907	CcSEcCtD
Sertraline—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000212	0.00552	CbGpPWpGaD
Sertraline—Tinnitus—Methotrexate—bone cancer	0.000212	0.000905	CcSEcCtD
Sertraline—Hypoaesthesia—Epirubicin—bone cancer	0.000212	0.000904	CcSEcCtD
Sertraline—Asthenia—Cisplatin—bone cancer	0.000211	0.000902	CcSEcCtD
Sertraline—Pharyngitis—Epirubicin—bone cancer	0.000211	0.000902	CcSEcCtD
Sertraline—Cardiac disorder—Methotrexate—bone cancer	0.000211	0.000901	CcSEcCtD
Sertraline—Sweating—Doxorubicin—bone cancer	0.00021	0.000898	CcSEcCtD
Sertraline—Urinary tract disorder—Epirubicin—bone cancer	0.00021	0.000897	CcSEcCtD
Sertraline—Oedema peripheral—Epirubicin—bone cancer	0.00021	0.000895	CcSEcCtD
Sertraline—Haematuria—Doxorubicin—bone cancer	0.000209	0.000893	CcSEcCtD
Sertraline—Connective tissue disorder—Epirubicin—bone cancer	0.000209	0.000893	CcSEcCtD
Sertraline—Urethral disorder—Epirubicin—bone cancer	0.000209	0.000891	CcSEcCtD
Sertraline—Hepatobiliary disease—Doxorubicin—bone cancer	0.000207	0.000886	CcSEcCtD
Sertraline—Epistaxis—Doxorubicin—bone cancer	0.000207	0.000883	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—bone cancer	0.000206	0.000881	CcSEcCtD
Sertraline—Sinusitis—Doxorubicin—bone cancer	0.000206	0.000879	CcSEcCtD
Sertraline—Immune system disorder—Methotrexate—bone cancer	0.000205	0.000877	CcSEcCtD
Sertraline—Visual impairment—Epirubicin—bone cancer	0.000205	0.000876	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—bone cancer	0.000205	0.000875	CcSEcCtD
Sertraline—Agranulocytosis—Doxorubicin—bone cancer	0.000205	0.000874	CcSEcCtD
Sertraline—Chills—Methotrexate—bone cancer	0.000204	0.000871	CcSEcCtD
Sertraline—MAOB—Biological oxidations—GSTP1—bone cancer	0.000204	0.0053	CbGpPWpGaD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000202	0.00525	CbGpPWpGaD
Sertraline—Diarrhoea—Cisplatin—bone cancer	0.000201	0.00086	CcSEcCtD
Sertraline—Erythema multiforme—Epirubicin—bone cancer	0.000201	0.000859	CcSEcCtD
Sertraline—Alopecia—Methotrexate—bone cancer	0.000201	0.000858	CcSEcCtD
Sertraline—Bradycardia—Doxorubicin—bone cancer	0.0002	0.000856	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—bone cancer	0.000199	0.000851	CcSEcCtD
Sertraline—Eye disorder—Epirubicin—bone cancer	0.000199	0.000849	CcSEcCtD
Sertraline—Tinnitus—Epirubicin—bone cancer	0.000198	0.000847	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—bone cancer	0.000198	0.000845	CcSEcCtD
Sertraline—Erythema—Methotrexate—bone cancer	0.000198	0.000845	CcSEcCtD
Sertraline—Haemoglobin—Doxorubicin—bone cancer	0.000198	0.000845	CcSEcCtD
Sertraline—Flushing—Epirubicin—bone cancer	0.000198	0.000843	CcSEcCtD
Sertraline—Cardiac disorder—Epirubicin—bone cancer	0.000198	0.000843	CcSEcCtD
Sertraline—Rhinitis—Doxorubicin—bone cancer	0.000197	0.000843	CcSEcCtD
Sertraline—Haemorrhage—Doxorubicin—bone cancer	0.000197	0.000841	CcSEcCtD
Sertraline—Hepatitis—Doxorubicin—bone cancer	0.000197	0.000841	CcSEcCtD
Sertraline—Hypoaesthesia—Doxorubicin—bone cancer	0.000196	0.000836	CcSEcCtD
Sertraline—Pharyngitis—Doxorubicin—bone cancer	0.000195	0.000834	CcSEcCtD
Sertraline—Urinary tract disorder—Doxorubicin—bone cancer	0.000194	0.00083	CcSEcCtD
Sertraline—Oedema peripheral—Doxorubicin—bone cancer	0.000194	0.000828	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—bone cancer	0.000194	0.000828	CcSEcCtD
Sertraline—Connective tissue disorder—Doxorubicin—bone cancer	0.000194	0.000826	CcSEcCtD
Sertraline—Angiopathy—Epirubicin—bone cancer	0.000193	0.000824	CcSEcCtD
Sertraline—Urethral disorder—Doxorubicin—bone cancer	0.000193	0.000824	CcSEcCtD
Sertraline—Immune system disorder—Epirubicin—bone cancer	0.000192	0.000821	CcSEcCtD
Sertraline—Mediastinal disorder—Epirubicin—bone cancer	0.000192	0.000819	CcSEcCtD
Sertraline—Back pain—Methotrexate—bone cancer	0.000192	0.000817	CcSEcCtD
Sertraline—Chills—Epirubicin—bone cancer	0.000191	0.000815	CcSEcCtD
Sertraline—Arrhythmia—Epirubicin—bone cancer	0.00019	0.000812	CcSEcCtD
Sertraline—Visual impairment—Doxorubicin—bone cancer	0.00019	0.00081	CcSEcCtD
Sertraline—Alopecia—Epirubicin—bone cancer	0.000188	0.000803	CcSEcCtD
Sertraline—Vomiting—Cisplatin—bone cancer	0.000187	0.000799	CcSEcCtD
Sertraline—Mental disorder—Epirubicin—bone cancer	0.000186	0.000796	CcSEcCtD
Sertraline—Erythema multiforme—Doxorubicin—bone cancer	0.000186	0.000795	CcSEcCtD
Sertraline—Rash—Cisplatin—bone cancer	0.000186	0.000792	CcSEcCtD
Sertraline—Dermatitis—Cisplatin—bone cancer	0.000185	0.000792	CcSEcCtD
Sertraline—Malnutrition—Epirubicin—bone cancer	0.000185	0.000791	CcSEcCtD
Sertraline—Erythema—Epirubicin—bone cancer	0.000185	0.000791	CcSEcCtD
Sertraline—Eye disorder—Doxorubicin—bone cancer	0.000184	0.000786	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—bone cancer	0.000184	0.000784	CcSEcCtD
Sertraline—Tinnitus—Doxorubicin—bone cancer	0.000184	0.000784	CcSEcCtD
Sertraline—Anaemia—Methotrexate—bone cancer	0.000183	0.000781	CcSEcCtD
Sertraline—Cardiac disorder—Doxorubicin—bone cancer	0.000183	0.00078	CcSEcCtD
Sertraline—Flushing—Doxorubicin—bone cancer	0.000183	0.00078	CcSEcCtD
Sertraline—Flatulence—Epirubicin—bone cancer	0.000183	0.000779	CcSEcCtD
Sertraline—Tension—Epirubicin—bone cancer	0.000182	0.000776	CcSEcCtD
Sertraline—Dysgeusia—Epirubicin—bone cancer	0.000181	0.000774	CcSEcCtD
Sertraline—Nervousness—Epirubicin—bone cancer	0.00018	0.000768	CcSEcCtD
Sertraline—Back pain—Epirubicin—bone cancer	0.000179	0.000765	CcSEcCtD
Sertraline—Angiopathy—Doxorubicin—bone cancer	0.000179	0.000763	CcSEcCtD
Sertraline—Malaise—Methotrexate—bone cancer	0.000179	0.000762	CcSEcCtD
Sertraline—Muscle spasms—Epirubicin—bone cancer	0.000178	0.00076	CcSEcCtD
Sertraline—Immune system disorder—Doxorubicin—bone cancer	0.000178	0.000759	CcSEcCtD
Sertraline—Vertigo—Methotrexate—bone cancer	0.000178	0.000759	CcSEcCtD
Sertraline—SLC6A4—NRF2 pathway—TGFBR2—bone cancer	0.000178	0.00463	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—GSTP1—bone cancer	0.000178	0.00463	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—GNA11—bone cancer	0.000178	0.00462	CbGpPWpGaD
Sertraline—Mediastinal disorder—Doxorubicin—bone cancer	0.000177	0.000758	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—bone cancer	0.000177	0.000756	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—EZH2—bone cancer	0.000177	0.0046	CbGpPWpGaD
Sertraline—Chills—Doxorubicin—bone cancer	0.000177	0.000754	CcSEcCtD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000176	0.00459	CbGpPWpGaD
Sertraline—Arrhythmia—Doxorubicin—bone cancer	0.000176	0.000751	CcSEcCtD
Sertraline—Nausea—Cisplatin—bone cancer	0.000175	0.000747	CcSEcCtD
Sertraline—Alopecia—Doxorubicin—bone cancer	0.000174	0.000743	CcSEcCtD
Sertraline—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000174	0.00453	CbGpPWpGaD
Sertraline—Cough—Methotrexate—bone cancer	0.000173	0.000737	CcSEcCtD
Sertraline—Mental disorder—Doxorubicin—bone cancer	0.000173	0.000736	CcSEcCtD
Sertraline—Ill-defined disorder—Epirubicin—bone cancer	0.000172	0.000734	CcSEcCtD
Sertraline—Convulsion—Methotrexate—bone cancer	0.000172	0.000732	CcSEcCtD
Sertraline—Malnutrition—Doxorubicin—bone cancer	0.000171	0.000732	CcSEcCtD
Sertraline—Erythema—Doxorubicin—bone cancer	0.000171	0.000732	CcSEcCtD
Sertraline—Anaemia—Epirubicin—bone cancer	0.000171	0.000731	CcSEcCtD
Sertraline—Agitation—Epirubicin—bone cancer	0.00017	0.000727	CcSEcCtD
Sertraline—Flatulence—Doxorubicin—bone cancer	0.000169	0.000721	CcSEcCtD
Sertraline—Arthralgia—Methotrexate—bone cancer	0.000169	0.000719	CcSEcCtD
Sertraline—Chest pain—Methotrexate—bone cancer	0.000169	0.000719	CcSEcCtD
Sertraline—Myalgia—Methotrexate—bone cancer	0.000169	0.000719	CcSEcCtD
Sertraline—Tension—Doxorubicin—bone cancer	0.000168	0.000718	CcSEcCtD
Sertraline—Dysgeusia—Doxorubicin—bone cancer	0.000168	0.000717	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000167	0.000715	CcSEcCtD
Sertraline—Malaise—Epirubicin—bone cancer	0.000167	0.000713	CcSEcCtD
Sertraline—Discomfort—Methotrexate—bone cancer	0.000167	0.000711	CcSEcCtD
Sertraline—Nervousness—Doxorubicin—bone cancer	0.000167	0.000711	CcSEcCtD
Sertraline—Vertigo—Epirubicin—bone cancer	0.000166	0.000711	CcSEcCtD
Sertraline—Syncope—Epirubicin—bone cancer	0.000166	0.000709	CcSEcCtD
Sertraline—Leukopenia—Epirubicin—bone cancer	0.000166	0.000708	CcSEcCtD
Sertraline—Back pain—Doxorubicin—bone cancer	0.000166	0.000708	CcSEcCtD
Sertraline—Muscle spasms—Doxorubicin—bone cancer	0.000165	0.000704	CcSEcCtD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000164	0.00428	CbGpPWpGaD
Sertraline—Palpitations—Epirubicin—bone cancer	0.000164	0.000699	CcSEcCtD
Sertraline—Confusional state—Methotrexate—bone cancer	0.000163	0.000695	CcSEcCtD
Sertraline—Loss of consciousness—Epirubicin—bone cancer	0.000163	0.000695	CcSEcCtD
Sertraline—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000162	0.00422	CbGpPWpGaD
Sertraline—Cough—Epirubicin—bone cancer	0.000162	0.00069	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—bone cancer	0.000162	0.00069	CcSEcCtD
Sertraline—Convulsion—Epirubicin—bone cancer	0.000161	0.000685	CcSEcCtD
Sertraline—Hypertension—Epirubicin—bone cancer	0.00016	0.000683	CcSEcCtD
Sertraline—Ill-defined disorder—Doxorubicin—bone cancer	0.000159	0.000679	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—bone cancer	0.000158	0.000676	CcSEcCtD
Sertraline—Anaemia—Doxorubicin—bone cancer	0.000158	0.000676	CcSEcCtD
Sertraline—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000158	0.00412	CbGpPWpGaD
Sertraline—Thrombocytopenia—Methotrexate—bone cancer	0.000158	0.000675	CcSEcCtD
Sertraline—Chest pain—Epirubicin—bone cancer	0.000158	0.000673	CcSEcCtD
Sertraline—Arthralgia—Epirubicin—bone cancer	0.000158	0.000673	CcSEcCtD
Sertraline—Myalgia—Epirubicin—bone cancer	0.000158	0.000673	CcSEcCtD
Sertraline—Agitation—Doxorubicin—bone cancer	0.000158	0.000672	CcSEcCtD
Sertraline—Anxiety—Epirubicin—bone cancer	0.000157	0.000671	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—bone cancer	0.000157	0.00067	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000157	0.000669	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—bone cancer	0.000156	0.000667	CcSEcCtD
Sertraline—Discomfort—Epirubicin—bone cancer	0.000156	0.000665	CcSEcCtD
Sertraline—Malaise—Doxorubicin—bone cancer	0.000155	0.00066	CcSEcCtD
Sertraline—Dry mouth—Epirubicin—bone cancer	0.000154	0.000659	CcSEcCtD
Sertraline—Vertigo—Doxorubicin—bone cancer	0.000154	0.000657	CcSEcCtD
Sertraline—Anorexia—Methotrexate—bone cancer	0.000154	0.000657	CcSEcCtD
Sertraline—Syncope—Doxorubicin—bone cancer	0.000154	0.000656	CcSEcCtD
Sertraline—Leukopenia—Doxorubicin—bone cancer	0.000153	0.000655	CcSEcCtD
Sertraline—SLC6A2—NRF2 pathway—TGFBR2—bone cancer	0.000153	0.00398	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—GSTP1—bone cancer	0.000153	0.00398	CbGpPWpGaD
Sertraline—Confusional state—Epirubicin—bone cancer	0.000152	0.000651	CcSEcCtD
Sertraline—Palpitations—Doxorubicin—bone cancer	0.000152	0.000647	CcSEcCtD
Sertraline—Anaphylactic shock—Epirubicin—bone cancer	0.000151	0.000645	CcSEcCtD
Sertraline—Oedema—Epirubicin—bone cancer	0.000151	0.000645	CcSEcCtD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000151	0.00393	CbGpPWpGaD
Sertraline—Hypotension—Methotrexate—bone cancer	0.000151	0.000644	CcSEcCtD
Sertraline—Loss of consciousness—Doxorubicin—bone cancer	0.000151	0.000643	CcSEcCtD
Sertraline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00015	0.0039	CbGpPWpGaD
Sertraline—Cough—Doxorubicin—bone cancer	0.00015	0.000639	CcSEcCtD
Sertraline—MAOA—Biological oxidations—CYP3A4—bone cancer	0.000149	0.00389	CbGpPWpGaD
Sertraline—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000149	0.00388	CbGpPWpGaD
Sertraline—Shock—Epirubicin—bone cancer	0.000149	0.000635	CcSEcCtD
Sertraline—Convulsion—Doxorubicin—bone cancer	0.000149	0.000634	CcSEcCtD
Sertraline—Nervous system disorder—Epirubicin—bone cancer	0.000148	0.000633	CcSEcCtD
Sertraline—Thrombocytopenia—Epirubicin—bone cancer	0.000148	0.000632	CcSEcCtD
Sertraline—Hypertension—Doxorubicin—bone cancer	0.000148	0.000632	CcSEcCtD
Sertraline—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000148	0.00385	CbGpPWpGaD
Sertraline—Tachycardia—Epirubicin—bone cancer	0.000148	0.00063	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000147	0.000628	CcSEcCtD
Sertraline—Skin disorder—Epirubicin—bone cancer	0.000147	0.000627	CcSEcCtD
Sertraline—Hyperhidrosis—Epirubicin—bone cancer	0.000146	0.000624	CcSEcCtD
Sertraline—Insomnia—Methotrexate—bone cancer	0.000146	0.000624	CcSEcCtD
Sertraline—Myalgia—Doxorubicin—bone cancer	0.000146	0.000623	CcSEcCtD
Sertraline—Arthralgia—Doxorubicin—bone cancer	0.000146	0.000623	CcSEcCtD
Sertraline—Chest pain—Doxorubicin—bone cancer	0.000146	0.000623	CcSEcCtD
Sertraline—Anxiety—Doxorubicin—bone cancer	0.000145	0.000621	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—bone cancer	0.000145	0.000619	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000145	0.000619	CcSEcCtD
Sertraline—Discomfort—Doxorubicin—bone cancer	0.000144	0.000616	CcSEcCtD
Sertraline—Anorexia—Epirubicin—bone cancer	0.000144	0.000615	CcSEcCtD
Sertraline—Dyspnoea—Methotrexate—bone cancer	0.000144	0.000615	CcSEcCtD
Sertraline—Somnolence—Methotrexate—bone cancer	0.000144	0.000613	CcSEcCtD
Sertraline—Dry mouth—Doxorubicin—bone cancer	0.000143	0.000609	CcSEcCtD
Sertraline—MAOB—Metabolism—NDUFA12—bone cancer	0.000143	0.00372	CbGpPWpGaD
Sertraline—Dyspepsia—Methotrexate—bone cancer	0.000142	0.000607	CcSEcCtD
Sertraline—Hypotension—Epirubicin—bone cancer	0.000141	0.000603	CcSEcCtD
Sertraline—Confusional state—Doxorubicin—bone cancer	0.000141	0.000602	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—bone cancer	0.00014	0.0006	CcSEcCtD
Sertraline—Anaphylactic shock—Doxorubicin—bone cancer	0.00014	0.000597	CcSEcCtD
Sertraline—Oedema—Doxorubicin—bone cancer	0.00014	0.000597	CcSEcCtD
Sertraline—Gastrointestinal disorder—Methotrexate—bone cancer	0.00014	0.000595	CcSEcCtD
Sertraline—Fatigue—Methotrexate—bone cancer	0.000139	0.000595	CcSEcCtD
Sertraline—Pain—Methotrexate—bone cancer	0.000138	0.00059	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000138	0.000588	CcSEcCtD
Sertraline—Shock—Doxorubicin—bone cancer	0.000138	0.000588	CcSEcCtD
Sertraline—Nervous system disorder—Doxorubicin—bone cancer	0.000137	0.000586	CcSEcCtD
Sertraline—Thrombocytopenia—Doxorubicin—bone cancer	0.000137	0.000585	CcSEcCtD
Sertraline—Insomnia—Epirubicin—bone cancer	0.000137	0.000584	CcSEcCtD
Sertraline—Tachycardia—Doxorubicin—bone cancer	0.000137	0.000583	CcSEcCtD
Sertraline—Skin disorder—Doxorubicin—bone cancer	0.000136	0.00058	CcSEcCtD
Sertraline—Paraesthesia—Epirubicin—bone cancer	0.000136	0.00058	CcSEcCtD
Sertraline—SLC6A3—NRF2 pathway—TGFBR2—bone cancer	0.000135	0.00353	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—GSTP1—bone cancer	0.000135	0.00353	CbGpPWpGaD
Sertraline—Hyperhidrosis—Doxorubicin—bone cancer	0.000135	0.000577	CcSEcCtD
Sertraline—Dyspnoea—Epirubicin—bone cancer	0.000135	0.000575	CcSEcCtD
Sertraline—Somnolence—Epirubicin—bone cancer	0.000134	0.000574	CcSEcCtD
Sertraline—Anorexia—Doxorubicin—bone cancer	0.000133	0.000569	CcSEcCtD
Sertraline—Feeling abnormal—Methotrexate—bone cancer	0.000133	0.000568	CcSEcCtD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000133	0.00347	CbGpPWpGaD
Sertraline—Dyspepsia—Epirubicin—bone cancer	0.000133	0.000568	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—bone cancer	0.000132	0.000564	CcSEcCtD
Sertraline—Decreased appetite—Epirubicin—bone cancer	0.000131	0.000561	CcSEcCtD
Sertraline—Hypotension—Doxorubicin—bone cancer	0.000131	0.000558	CcSEcCtD
Sertraline—Gastrointestinal disorder—Epirubicin—bone cancer	0.000131	0.000557	CcSEcCtD
Sertraline—Fatigue—Epirubicin—bone cancer	0.00013	0.000556	CcSEcCtD
Sertraline—Constipation—Epirubicin—bone cancer	0.000129	0.000552	CcSEcCtD
Sertraline—Pain—Epirubicin—bone cancer	0.000129	0.000552	CcSEcCtD
Sertraline—Urticaria—Methotrexate—bone cancer	0.000128	0.000548	CcSEcCtD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000128	0.00333	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—GSTP1—bone cancer	0.000128	0.00333	CbGpPWpGaD
Sertraline—Abdominal pain—Methotrexate—bone cancer	0.000128	0.000545	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—bone cancer	0.000128	0.000545	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000127	0.000544	CcSEcCtD
Sertraline—Insomnia—Doxorubicin—bone cancer	0.000127	0.00054	CcSEcCtD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000126	0.00329	CbGpPWpGaD
Sertraline—Paraesthesia—Doxorubicin—bone cancer	0.000126	0.000536	CcSEcCtD
Sertraline—Dyspnoea—Doxorubicin—bone cancer	0.000125	0.000532	CcSEcCtD
Sertraline—Feeling abnormal—Epirubicin—bone cancer	0.000125	0.000532	CcSEcCtD
Sertraline—Somnolence—Doxorubicin—bone cancer	0.000124	0.000531	CcSEcCtD
Sertraline—Gastrointestinal pain—Epirubicin—bone cancer	0.000124	0.000528	CcSEcCtD
Sertraline—Dyspepsia—Doxorubicin—bone cancer	0.000123	0.000526	CcSEcCtD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000122	0.00319	CbGpPWpGaD
Sertraline—Decreased appetite—Doxorubicin—bone cancer	0.000122	0.000519	CcSEcCtD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000121	0.00316	CbGpPWpGaD
Sertraline—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000121	0.000516	CcSEcCtD
Sertraline—Fatigue—Doxorubicin—bone cancer	0.000121	0.000515	CcSEcCtD
Sertraline—SLC6A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00012	0.00313	CbGpPWpGaD
Sertraline—Urticaria—Epirubicin—bone cancer	0.00012	0.000513	CcSEcCtD
Sertraline—Pain—Doxorubicin—bone cancer	0.00012	0.000511	CcSEcCtD
Sertraline—Constipation—Doxorubicin—bone cancer	0.00012	0.000511	CcSEcCtD
Sertraline—Abdominal pain—Epirubicin—bone cancer	0.00012	0.00051	CcSEcCtD
Sertraline—Body temperature increased—Epirubicin—bone cancer	0.00012	0.00051	CcSEcCtD
Sertraline—Hypersensitivity—Methotrexate—bone cancer	0.000119	0.000508	CcSEcCtD
Sertraline—MAOB—Metabolism—NT5C3A—bone cancer	0.000118	0.00308	CbGpPWpGaD
Sertraline—Asthenia—Methotrexate—bone cancer	0.000116	0.000495	CcSEcCtD
Sertraline—Feeling abnormal—Doxorubicin—bone cancer	0.000115	0.000492	CcSEcCtD
Sertraline—Gastrointestinal pain—Doxorubicin—bone cancer	0.000114	0.000488	CcSEcCtD
Sertraline—Pruritus—Methotrexate—bone cancer	0.000114	0.000488	CcSEcCtD
Sertraline—Hypersensitivity—Epirubicin—bone cancer	0.000111	0.000476	CcSEcCtD
Sertraline—Urticaria—Doxorubicin—bone cancer	0.000111	0.000474	CcSEcCtD
Sertraline—Body temperature increased—Doxorubicin—bone cancer	0.000111	0.000472	CcSEcCtD
Sertraline—Abdominal pain—Doxorubicin—bone cancer	0.000111	0.000472	CcSEcCtD
Sertraline—Diarrhoea—Methotrexate—bone cancer	0.000111	0.000472	CcSEcCtD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00011	0.00287	CbGpPWpGaD
Sertraline—Asthenia—Epirubicin—bone cancer	0.000108	0.000463	CcSEcCtD
Sertraline—Pruritus—Epirubicin—bone cancer	0.000107	0.000457	CcSEcCtD
Sertraline—Dizziness—Methotrexate—bone cancer	0.000107	0.000456	CcSEcCtD
Sertraline—SLC6A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000106	0.00277	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000104	0.0027	CbGpPWpGaD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000104	0.0027	CbGpPWpGaD
Sertraline—Diarrhoea—Epirubicin—bone cancer	0.000103	0.000442	CcSEcCtD
Sertraline—Hypersensitivity—Doxorubicin—bone cancer	0.000103	0.00044	CcSEcCtD
Sertraline—Vomiting—Methotrexate—bone cancer	0.000103	0.000439	CcSEcCtD
Sertraline—Rash—Methotrexate—bone cancer	0.000102	0.000435	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—bone cancer	0.000102	0.000434	CcSEcCtD
Sertraline—Headache—Methotrexate—bone cancer	0.000101	0.000432	CcSEcCtD
Sertraline—Asthenia—Doxorubicin—bone cancer	0.0001	0.000428	CcSEcCtD
Sertraline—Dizziness—Epirubicin—bone cancer	0.0001	0.000427	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—CDK4—bone cancer	9.98e-05	0.0026	CbGpPWpGaD
Sertraline—Pruritus—Doxorubicin—bone cancer	9.9e-05	0.000423	CcSEcCtD
Sertraline—Vomiting—Epirubicin—bone cancer	9.61e-05	0.00041	CcSEcCtD
Sertraline—Nausea—Methotrexate—bone cancer	9.6e-05	0.00041	CcSEcCtD
Sertraline—Diarrhoea—Doxorubicin—bone cancer	9.57e-05	0.000409	CcSEcCtD
Sertraline—Rash—Epirubicin—bone cancer	9.53e-05	0.000407	CcSEcCtD
Sertraline—Dermatitis—Epirubicin—bone cancer	9.53e-05	0.000407	CcSEcCtD
Sertraline—Headache—Epirubicin—bone cancer	9.47e-05	0.000404	CcSEcCtD
Sertraline—CYP2B6—Biological oxidations—CYP3A4—bone cancer	9.36e-05	0.00244	CbGpPWpGaD
Sertraline—Dizziness—Doxorubicin—bone cancer	9.25e-05	0.000395	CcSEcCtD
Sertraline—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	9.23e-05	0.0024	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.19e-05	0.00239	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9e-05	0.00235	CbGpPWpGaD
Sertraline—Nausea—Epirubicin—bone cancer	8.98e-05	0.000383	CcSEcCtD
Sertraline—MAOA—Metabolism—NDUFA12—bone cancer	8.96e-05	0.00233	CbGpPWpGaD
Sertraline—Vomiting—Doxorubicin—bone cancer	8.9e-05	0.00038	CcSEcCtD
Sertraline—Rash—Doxorubicin—bone cancer	8.82e-05	0.000377	CcSEcCtD
Sertraline—Dermatitis—Doxorubicin—bone cancer	8.81e-05	0.000376	CcSEcCtD
Sertraline—Headache—Doxorubicin—bone cancer	8.77e-05	0.000374	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.53e-05	0.00222	CbGpPWpGaD
Sertraline—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	8.42e-05	0.00219	CbGpPWpGaD
Sertraline—Nausea—Doxorubicin—bone cancer	8.31e-05	0.000355	CcSEcCtD
Sertraline—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.06e-05	0.0021	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTP1—bone cancer	8e-05	0.00208	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	7.89e-05	0.00206	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—JUN—bone cancer	7.87e-05	0.00205	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	7.68e-05	0.002	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.66e-05	0.00199	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NT5C3A—bone cancer	7.42e-05	0.00193	CbGpPWpGaD
Sertraline—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.27e-05	0.00189	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	7.26e-05	0.00189	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP3A4—bone cancer	7.07e-05	0.00184	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.01e-05	0.00183	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	6.98e-05	0.00182	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	6.97e-05	0.00182	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—BRAF—bone cancer	6.75e-05	0.00176	CbGpPWpGaD
Sertraline—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	6.56e-05	0.00171	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.5e-05	0.00169	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	6.45e-05	0.00168	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.45e-05	0.00168	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—JUN—bone cancer	6.43e-05	0.00167	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.42e-05	0.00167	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.36e-05	0.00166	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.35e-05	0.00165	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.32e-05	0.00165	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.26e-05	0.00163	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	6.09e-05	0.00159	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTP1—bone cancer	6.05e-05	0.00158	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	5.97e-05	0.00155	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	5.93e-05	0.00155	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—MDM2—bone cancer	5.66e-05	0.00147	CbGpPWpGaD
Sertraline—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.61e-05	0.00146	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NDUFA12—bone cancer	5.61e-05	0.00146	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—BRAF—bone cancer	5.57e-05	0.00145	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.56e-05	0.00145	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.52e-05	0.00144	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.51e-05	0.00144	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.49e-05	0.00143	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.44e-05	0.00142	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.43e-05	0.00142	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.31e-05	0.00138	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.29e-05	0.00138	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ENO2—bone cancer	5.18e-05	0.00135	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—BRAF—bone cancer	5.17e-05	0.00135	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.97e-05	0.00129	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.97e-05	0.00129	CbGpPWpGaD
Sertraline—MAOB—Metabolism—DHFR—bone cancer	4.81e-05	0.00125	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.71e-05	0.00123	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—MDM2—bone cancer	4.66e-05	0.00121	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NT5C3A—bone cancer	4.65e-05	0.00121	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.65e-05	0.00121	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.57e-05	0.00119	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GNA11—bone cancer	4.49e-05	0.00117	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—MDM2—bone cancer	4.33e-05	0.00113	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—bone cancer	4.24e-05	0.00111	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NDUFA12—bone cancer	4.24e-05	0.0011	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NDUFA12—bone cancer	4.14e-05	0.00108	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP3A4—bone cancer	4.07e-05	0.00106	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.94e-05	0.00103	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NDUFA12—bone cancer	3.9e-05	0.00102	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NDUFA12—bone cancer	3.87e-05	0.00101	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.64e-05	0.000947	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.59e-05	0.000934	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NT5C3A—bone cancer	3.51e-05	0.000915	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTP1—bone cancer	3.48e-05	0.000907	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NT5C3A—bone cancer	3.43e-05	0.000893	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NDUFA12—bone cancer	3.3e-05	0.00086	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ENO2—bone cancer	3.25e-05	0.000847	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NT5C3A—bone cancer	3.23e-05	0.000842	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NT5C3A—bone cancer	3.2e-05	0.000834	CbGpPWpGaD
Sertraline—MAOA—Metabolism—DHFR—bone cancer	3.02e-05	0.000785	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.92e-05	0.00076	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GNA11—bone cancer	2.82e-05	0.000734	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.81e-05	0.000733	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NT5C3A—bone cancer	2.74e-05	0.000713	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP3A4—bone cancer	2.56e-05	0.000666	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NDUFA12—bone cancer	2.55e-05	0.000664	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.54e-05	0.000661	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTP1—bone cancer	2.19e-05	0.000569	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NT5C3A—bone cancer	2.11e-05	0.00055	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ENO2—bone cancer	2.04e-05	0.00053	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.99e-05	0.000519	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—DHFR—bone cancer	1.89e-05	0.000492	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—bone cancer	1.8e-05	0.00047	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GNA11—bone cancer	1.77e-05	0.00046	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.67e-05	0.000436	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP3A4—bone cancer	1.6e-05	0.000417	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ENO2—bone cancer	1.54e-05	0.000401	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ENO2—bone cancer	1.5e-05	0.000391	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—DHFR—bone cancer	1.43e-05	0.000372	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ENO2—bone cancer	1.42e-05	0.000369	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ENO2—bone cancer	1.4e-05	0.000365	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—DHFR—bone cancer	1.39e-05	0.000363	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTP1—bone cancer	1.37e-05	0.000357	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GNA11—bone cancer	1.33e-05	0.000347	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—DHFR—bone cancer	1.31e-05	0.000342	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GNA11—bone cancer	1.3e-05	0.000339	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—DHFR—bone cancer	1.3e-05	0.000339	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GNA11—bone cancer	1.23e-05	0.00032	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GNA11—bone cancer	1.22e-05	0.000317	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP3A4—bone cancer	1.21e-05	0.000315	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.2e-05	0.000313	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ENO2—bone cancer	1.2e-05	0.000312	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP3A4—bone cancer	1.18e-05	0.000307	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—bone cancer	1.13e-05	0.000295	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP3A4—bone cancer	1.11e-05	0.00029	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—DHFR—bone cancer	1.11e-05	0.00029	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000287	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.1e-05	0.000286	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GNA11—bone cancer	1.04e-05	0.000271	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTP1—bone cancer	1.03e-05	0.000269	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTP1—bone cancer	1.01e-05	0.000263	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTP1—bone cancer	9.51e-06	0.000248	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTP1—bone cancer	9.43e-06	0.000246	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP3A4—bone cancer	9.42e-06	0.000245	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.38e-06	0.000244	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ENO2—bone cancer	9.25e-06	0.000241	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—DHFR—bone cancer	8.58e-06	0.000224	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTP1—bone cancer	8.06e-06	0.00021	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GNA11—bone cancer	8.02e-06	0.000209	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—bone cancer	7.09e-06	0.000185	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTP1—bone cancer	6.22e-06	0.000162	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—bone cancer	5.36e-06	0.00014	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—bone cancer	5.23e-06	0.000136	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—bone cancer	4.93e-06	0.000128	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—bone cancer	4.89e-06	0.000127	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—bone cancer	4.18e-06	0.000109	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—bone cancer	3.22e-06	8.39e-05	CbGpPWpGaD
